Cargando…

Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma

INTRODUCTION: An increasing number of targeted drugs have been tested for the treatment of nasopharyngeal carcinoma (NPC). However, targeted therapy-related oncogenic mutations have not been fully evaluated. This study aimed to detect targeted therapy-related oncogenic mutations in NPC and to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jian-Wei, Qin, Tao, Hong, Shao-Dong, Zhang, Jing, Fang, Wen-Feng, Zhao, Yuan-Yuan, Yang, Yun-Peng, Xue, Cong, Huang, Yan, Zhao, Hong-Yuan, Ma, Yu-Xiang, Hu, Zhi-Huang, Huang, Pei-Yu, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593383/ https://www.ncbi.nlm.nih.gov/pubmed/25963410 http://dx.doi.org/10.1186/s40880-015-0011-0

Ejemplares similares

Oncogene mutational profile in nasopharyngeal carcinoma
por: Zhang, Zi-Chen, et al.
Publicado: (2014)

Expression of RRM1 and its association with resistancy to gemcitabine-based chemotherapy in advanced nasopharyngeal carcinoma
por: Zhao, Li-Ping, et al.
Publicado: (2012)

Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo
por: Zhao, Yuan-Yuan, et al.
Publicado: (2014)

Clinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma
por: Zhang, Xin-ke, et al.
Publicado: (2015)

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
por: Zhang, Jian-Wei, et al.
Publicado: (2014)

A novel oncogenic seRNA promotes nasopharyngeal carcinoma metastasis
por: Tan, Yuan, et al.
Publicado: (2022)

The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis From 9 Randomized Controlled Trials
por: Sheng, Jin, et al.
Publicado: (2015)

Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis
por: Chen, Ming-Yuan, et al.
Publicado: (2013)

QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC
por: Yang, Yun-Peng, et al.
Publicado: (2015)

HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis
por: Li, Qi-Guang, et al.
Publicado: (2020)

Neoantigen landscape in metastatic nasopharyngeal carcinoma
por: Lin, Mei, et al.
Publicado: (2021)

Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance
por: Lin, Mei, et al.
Publicado: (2023)

Effects and mechanisms of innate immune molecules on inhibiting nasopharyngeal carcinoma
por: Xiong, Fang, et al.
Publicado: (2019)

Molecular Prognostic Prediction for Locally Advanced Nasopharyngeal Carcinoma by Support Vector Machine Integrated Approach
por: Wan, Xiang-Bo, et al.
Publicado: (2012)

Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2016)

Association between Pretreatment Serum High-density Lipoprotein Cholesterol and Treatment Outcomes in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy: Findings from a Randomised Trial
por: Wang, Cheng-Tao, et al.
Publicado: (2019)

Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients
por: Li, Xiang, et al.
Publicado: (2023)

Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
por: Liu, You-Ping, et al.
Publicado: (2019)

Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review
por: Huang, Donglan, et al.
Publicado: (2021)

A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma
por: Zou, Xiong, et al.
Publicado: (2018)

Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma
por: Zhao, Yuan-yuan, et al.
Publicado: (2018)

A Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma
por: Zhang, Yang, et al.
Publicado: (2022)

Prognostic Value of Classifying Parapharyngeal Extension in Nasopharyngeal Carcinoma Based on Magnetic Resonance Imaging
por: Zhang, Guo-Yi, et al.
Publicado: (2015)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

SPARC expression and prognostic value in non-small cell lung cancer
por: Huang, Yan, et al.
Publicado: (2012)

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy
por: Liu, Huai, et al.
Publicado: (2013)

The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy
por: Guo, Shan-Shan, et al.
Publicado: (2014)

Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis
por: Wang, Ya-Qin, et al.
Publicado: (2019)

Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic Review
por: Sheng, Jin, et al.
Publicado: (2015)

Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area
por: Zeng, Qi, et al.
Publicado: (2016)

Investigation of the Definition of De Novo Oligometastatic Nasopharyngeal Carcinoma: A Retrospective Study
por: Wang, Hongmei, et al.
Publicado: (2021)

Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs
por: Sheng, Jin, et al.
Publicado: (2016)

Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma
por: Yuan, Qi, et al.
Publicado: (2023)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
por: Fang, Wenfeng, et al.
Publicado: (2014)

With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case–control study
por: Liu, Li-Ting, et al.
Publicado: (2016)

Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)

Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma
por: Hua, Xin, et al.
Publicado: (2020)

A Comprehensive Review on Radiomics and Deep Learning for Nasopharyngeal Carcinoma Imaging
por: Li, Song, et al.
Publicado: (2021)

MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5
por: Fang, Yuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_23npd0cbj38uos9aen2cgqaddd